In this Earth Day episode of the podcast, Joe interviews publisher, ecologist, planetary steward, and co-owner of Synergetic Press, Deborah Snyder. They discuss Biosphere 2 and how psychedelics and ecological spaces overlap.
www.psychedelicstoday.com
In this episode of the podcast, Joe speaks in-person with chemist and drug researcher, William Leonard Pickard; famous for being sentenced to two life sentences in 2004 for the alleged manufacture of 90% of the world’s LSD.
www.psychedelicstoday.com
In this episode of Vital Psychedelic Conversations, David interviews certified death doula and founder of the Diaspora Psychedelic Society, Omar Thomas. They discuss psychedelics and parenting; investing in Jamaica; and death.
www.psychedelicstoday.com
In this episode of the podcast, David interviews lawyer and activist, Jon Dennis, Esq. Dennis has been heavily involved in Oregon’s Measure 109, and discusses his proposed framework for protecting religious freedom and access.
www.psychedelicstoday.com
In this episode of Vital Psychedelic Conversations, Kyle interviews clinical psychologist, Dr. Ido Cohen. They discuss integration and how commitment to ourselves through the process can lead to long-lasting, sustainable change.
www.psychedelicstoday.com
In this episode of the podcast, Joe interviews Special Counsel at Emerge Law Group, Kathryn Tucker, JD, who has been protecting the rights of the terminally ill for 35 years and was part of the team behind Oregon's Measure 109.
www.psychedelicstoday.com
In this episode of Vital Psychedelic Conversations, Kyle interviews Senior Lead of Psychedelic Programs with Numinus Wellness, Dr. Devon Christie. She talks about biomedical ethics, mindfulness, and informed consent and touch.
www.psychedelicstoday.com
In this episode of the podcast, Joe interviews spirit healer, geomancer, and author of the new book, “Journeys With Plant Spirits: Plan Consciousness Healing & Natural Magic Practices,” Emma Farrell.
www.psychedelicstoday.com
In this episode of Vital Psychedelic Conversations, Kyle interviews professor of anthropology and historian, Jerry B. Brown, Ph.D., who co-authored "The Psychedelic Gospels: The Secret History of Hallucinogens in Christianity."
www.psychedelicstoday.com
In this episode of the podcast, Joe interviews Adam Bramlage: Founder and CEO of Flow State Micro, a functional mushroom company and microdosing educational platform. He discusses historic use (and microdosing) of psychedelics.
www.psychedelicstoday.com
In this episode of Vital Psychedelic Conversations, Kyle interviews Dr. Adele Lafrance: psychologist, author, researcher, and developer of Emotion-Focused Family Therapy, which focuses on the role of family in psychedelic work.
www.psychedelicstoday.com
In this episode of the podcast, David interviews Chief of Staff and Head of Operations at Nue Life, Kabir Ali. Ali discusses ketamine-assisted therapy, addiction, health coaching, and the overlooked gift of self-love.
In this episode of Vital Psychedelic Conversations, Kyle and David interview the author of “No Bad Parts: Healing Trauma and Restoring Wholeness with the Internal Family Systems Model" and IFS creator: Dr. Richard C. Schwartz.
In this episode of the podcast, Joe interviews Ed Prideaux: UK-based journalist working to raise awareness around Hallucinogen Persisting Perception Disorder (HPPD) in affiliation with the Perception Restoration Foundation.
www.psychedelicstoday.com
In this episode of Vital Psychedelic Conversations, Kyle interviews clinical psychologist, writer and researcher, Michael Sapiro. They discuss the importance of continued training, when to intervene, and mainstreaming mysticism.
www.psychedelicstoday.com
In this episode of the podcast, Kyle interviews Laura Mae Northrup, LMFT: educator, podcaster, somatic psychotherapist, and author of "Radical Healership: How to Build a Values-Driven Healing Practice in a Profit-Driven World."
www.psychedelicstoday.com
In this episode of Vital Psychedelic Conversations, Kyle interviews researcher, author, and Co-Founder/Director of the Breaking Convention conference: Dr. David Luke. He discusses DMT entity encounters and the transpersonal.
www.psychedelicstoday.com
In this episode of the podcast, Joe interviews author and Professor of Neuroscience at Universidade Federal do Rio Grande do Norte in Brazil: Sidarta Ribeiro. They discuss dreams, set and setting, LSD, jurema, and biopiracy.
www.psychedelicstoday.com
In this episode of Vital Psychedelic Conversations, David interviews two Vital teachers from The Center for Optimal Living in NYC; Founder/Director, Andrew Tatarsky, Ph.D., and Juliana Mulligan: Psychedelic Program Coordinator.
www.psychedelicstoday.com
In this episode of the podcast, Joe and Kyle finally interview one of their all-time heroes: Stanislav Grof, MD, Ph.D., who joins them with his wife and collaborator (and co-creator of Grof® Legacy Training), Brigitte Grof, MA.
www.psychedelicstoday.com
In this episode of Vital Psychedelic Conversations, Kyle interviews Sam Gandy: researcher and Ph.D. ecologist who is most interested in the capacity of psychedelics to amplify or ignite our relationship with nature.
www.psychedelicstoday.com
In this episode of the podcast, Joe interviews Rick Tarnas and Sean Kelly, Ph.D., coeditors of Psyche Unbound: Essays in Honor of Stanislav Grof, a new collection of 22 essays from the last 50 years on the impact of Grof's work.
www.psychedelicstoday.com
In this episode of Vital Psychedelic Conversations, Kyle interviews author and breathwork practitioner, Kylea Taylor, MS, LMFT. She discusses breathwork, spiritual emergency, her InnerEthics® program, and dreams about tripping.
www.psychedelicstoday.com
In this episode of the podcast, Joe interviews Co-Founder and CEO of Numinus, Payton Nyquvest, who talks about chronic pain, ayahuasca, Health Canada's Special Access Program, the importance of a therapeutic container, and more.
www.psychedelicstoday.com
In this episode of the podcast, Joe interviews Greg McKee: Chairman and CEO of Tryp Therapeutics, an early-stage biotech company researching the use of psilocybin derivatives to alleviate nociplastic pain like fibromyalgia.